RP

Rathnagiri Polavarapu

Active Director Director DIN 02104309
DIN 02104309 First appointment Jan 2007 Primary industry Life Sciences
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Jan 2007
Shareholding value •••• Premium profile

About Rathnagiri Polavarapu

Data last updated:

Rathnagiri Polavarapu is a Director at Genomix Molecular Diagnostics Private Limited (since 2007), Director at Genomix Carl Private Limited (since 2015) and Director at Genomix Healthcare (India) Private Limited (since 2010). The companies operate in Life Sciences, Trading and Chemicals. The 3 current companies with reported revenue have a combined latest revenue of ₹2.63 Cr; the largest is Genomix Molecular Diagnostics Private Limited at ₹2.21 Cr (FY 2025). Earlier, Rathnagiri Polavarapu was a Director at Epower Renew Energy (India) Private Limited (from 2013).

DIN 02104309
Primary Designation Director
Industry Life Sciences
First Appointment 03 Jan 2007
Oldest Company Age 19 yrs
Largest company Genomix Molecular Diagnostics Private Limited · ₹2.21 Cr (FY 2025)
Combined revenue ₹2.63 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Jan 20072007₹2.21 Cr (FY 2025)Active
Genomix Carl Private Limited U24233AP2015PTC097794
Director26 Nov 20152015₹40.2 Lakh (FY 2025)Active
Director01 Sep 20102010₹1.5 Lakh (FY 2017)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Mar 20132013Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Genomix Healthcare (India) Private Limited
Genomix Carl Private Limited
Epower Renew Energy (India) Private Limited
Genomix Molecular Diagnostics Private Limited
Premium access

Shareholding and investment profile for Rathnagiri Polavarapu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rathnagiri Polavarapu

Rathnagiri Polavarapu currently holds 3 directorships: Genomix Molecular Diagnostics Private Limited (Director, since 03 Jan 2007, revenue ₹2.21 Cr (FY 2025)); Genomix Carl Private Limited (Director, since 26 Nov 2015, revenue ₹40.2 Lakh (FY 2025)); Genomix Healthcare (India) Private Limited (Director, since 01 Sep 2010, revenue ₹1.5 Lakh (FY 2017)).

Rathnagiri Polavarapu was first appointed on 03 Jan 2007 as Director at Genomix Molecular Diagnostics Private Limited. The most recent appointment on record is 26 Nov 2015 at Genomix Carl Private Limited.

The 3 current companies of Rathnagiri Polavarapu that report revenue have a combined latest revenue of ₹2.63 Cr: Genomix Molecular Diagnostics Private Limited ₹2.21 Cr (FY 2025); Genomix Carl Private Limited ₹40.2 Lakh (FY 2025); Genomix Healthcare (India) Private Limited ₹1.5 Lakh (FY 2017).

Rathnagiri Polavarapu held 1 earlier board appointment: Epower Renew Energy (India) Private Limited (Director, from 20 Mar 2013).

The current boards of Rathnagiri Polavarapu's companies include Bilhan Kavikishore Polavarapu (Genomix Molecular Diagnostics Private Limited), Vijay Kumar Kanthamneni (Genomix Molecular Diagnostics Private Limited), Rama Naik Sankara (Genomix Carl Private Limited), Somasekharam Guthula (Genomix Carl Private Limited), Ojasvi Polavarapu (Genomix Healthcare (India) Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available